Contract
Exhibit 10.2
0000 Xxxxxx Xxxxx, Xxxxx 000
Xxxxxxxxxx, XX 00000
Phone: 000-000-0000, Fax: 000-000-0000
July 26, 2013
Xxxxxxx Xxxxx
Senior Marketing Director
Medtronic, Inc.
0000 Xxxxx Xxx Xxxxxx XX
Xxxxxx Xxxx, XX 00000
RE: Clinical Trial Collaboration Agreement dated April 18, 2013 between ARCA biopharma, Inc., and Medtronic, Inc.
Dear Xxxxxxx:
When countersigned by Medtronic, this letter shall serve as a permanent waiver of Medtronic’s rights under Section 8.2 (f), and ARCA’s rights under Section 8.3 (e) of the above-referenced Agreement.
|
|
Very truly yours, |
|
|
|
|
|
/s/ Xxxxxxxxxxx X. Xxxxxxx |
|
|
Xxxxxxxxxxx X. Xxxxxxx |
Accepted and Agreed this ____31st____ day of July, 2013:
|
|
|
|
|
Medtronic, Inc. |
| |
|
|
|
|
|
|
|
|
|
By: |
/s/ Xxxxxxx Xxxxx |
|
|
|
|
|
|
|
|
|
|
Its: |
Senior Marketing Director |
|
